JNJ
$JNJ
Johnson & Johnson
Diversified healthcare company with pharmaceuticals, medical devices, and consumer products.
HealthcareSubscribers
0
Tracking this ticker
Next Report
—
Weekly updates
Latest Report
This week's analysis
JNJ: Defensive Growth Play with Pipeline Momentum
Johnson & Johnson is trading near $243 as of Thursday, April 2, backed by a strong analyst consensus and pipeline wins in oncology and medtech. Upcoming Q1 results and trial readouts will be key near-term catalysts.
Apr 5, 2026